Research News

A new role for exosomes in type 2 diabetes

2. 11. 2017 | In healthy people, a type of exosomes – tiny structures secreted by cells to allow intercellular communication – prevent clumping of a protein that leads to type 2 diabetes. In patients with the disease, these vesicles don’t have the same ability. These are the results of a new study by AcademiaNet member Professor Pernilla Wittung Stafshede.
Professor Pernilla Wittung Stafshede
Bild vergrößern
(© Anna-Lena Lundqvist )


Professor Pernilla Wittung Stafshede

Proteins are the cell’s workhorses. These macromolecules are made up of long chains of amino acids which fold into specific three-dimensional structures. Sometimes, however, they fold incorrectly and aggregate into long fibres called amyloids. Once the amyloids accumulate, they can cause diseases. This happens, for example, in the brains of people with Alzheimer's (which develop amyloid plaques). Protein aggregation can also cause diabetes type 2, which is characterised by a deposition of islet amyloid polypeptide (IAPP) in the pancreas. Now, a team of scientists led by Professor Pernilla Wittung Stafshede has unearthed a previously unknown role of exosomes in the development of the disease.


“What we’ve found is that exosomes secreted by the cells in the pancreas stop that process in healthy people and protect them from type 2 diabetes, while the exosomes of diabetes patients do not,” says Professor Wittung Stafshede. What the study shows is that “healthy” exosomes bind the protein that causes diabetes on the outside, preventing it from aggregating. However, the results do not explain why. We also don’t know if type 2 diabetes is caused by “sick” exosomes or if the disease itself causes them to malfunction.


“The next step is to make controlled models of the exosomes, whose membranes contain lipids and proteins, to understand exactly what component affects the diabetes protein. If we can find which lipid or protein in the exosome membrane leads to that effect, and can work out the mechanism.”


The study is actually a part of industrial doctoral student Diana Ribeiro’s thesis work, and a collaboration between Chalmers University and the pharmaceutical company Astrazeneca.


“She [Ribeiro] came up with the idea for the project herself,” says Prof Wittung Stafshede, who is Ribeiro’s academic advisor at Chalmers. “She had done some research on exosomes before and I had read a bit about their potential. It’s a fairly new and unexplored field, and honestly I didn’t think the experiments would work. Diana had access to pancreatic cells through Astrazeneca – something we’d never had access to before – and she conducted the studies very thoroughly, and this led us to our discovery.”


  (© Christian Borg / AcademiaNet)

More information

Original article

Source

Testimonials

  1. Read what our members say about AcademiaNet.

No more excuses!

  1. Please download the brochure "No more excuses" and read more about female experts in Europe, and about AcademiaNet.

News

  1. Studying the molecular clockwork

    This year's Nobel Prize for Medicine and Physiology went to three chronobiologists: Michael W. Young, Michael Rosbash and Jeffrey C. Hall. The award has put a spotlight on an exciting, yet rarely discussed, field of research. We spoke with Professor Martha Merrow from the Ludwig Maximilians University of Munich, who researches circadian clocks in different organisms. She told us about the inner clock of cells, how chronobiology could help us live healthier and the problem some individuals' chronotype.

  2. 24 AcademiaNet members receive ERC Consolidator grants

    This year's call sees more female recipients than last year, and nearly a quarter of them are AcademiaNet members.

  3. "Even the best antiviral treatment is not a cure"

    On 1 December 2017, the 30th World AIDS Day took place to raise awareness of one of the most destructive epidemics in human history. Despite major advances in HIV treatment in the last decades - which have greatly improved the life expectancy of infected individuals - the disease is far from being eradicated. Professor Marie Larsson from Linköping University in Sweden studies how HIV affects the cells of the immune system and renders individuals more vulnerable to infections by other viruses.

  4. We do not fight when we deal with science

    ‘We are scientists but we are still humans and we cannot close our eyes or ears to what’s happening around us.’ - Dr Gihan Kamel

  5. "Science is for everyone"

    Anna-Lena Scholz interviewed AcademiaNet project manager Eva Roth for her column "3 ½ questions" in the "Chancen Brief" of the German newspaper "Die Zeit". We translated the exchange.